Ondacetron injection site
Reading File
Finding Sources
Searching the Web
ondansetron injection site administration IV IM routes
Finding Sources
Reading File
Here is a complete summary of ondansetron injection site and administration:
Ondansetron Injection - Routes and Administration
Available Injection Formulations
- 2 mg/mL solution for injection (most common)
- 4 mg/2 mL (2 mg/mL) single-dose vials
Routes of Administration
1. Intravenous (IV) - Most Common Route
Slow IV Injection (bolus):
- Inject undiluted over at least 30 seconds, preferably over 2-5 minutes
- Standard dose: 8 mg (adults) for CINV; 4 mg for PONV
IV Infusion (diluted):
- Dilute in 50-100 mL of compatible fluid (0.9% NaCl, 5% Dextrose, etc.)
- Infuse over 15 minutes
- Given 30 minutes before chemotherapy
Continuous IV Infusion:
- 1 mg/hour for up to 24 hours (maintenance)
2. Intramuscular (IM)
- Inject as a slow IM injection (not less than 30 seconds)
- Dose is the same as IV: 8 mg for CINV, 4 mg for PONV
- IM and IV formulations are the same preparation (no dilution needed for IM)
- Systemic exposure is equivalent between IM and IV routes (per pharmacokinetic data)
Common IM injection sites:
- Deltoid muscle (upper arm) - most commonly used in adults
- Vastus lateralis (outer thigh) - preferred when deltoid not accessible
- Ventrogluteal / dorsogluteal - less commonly used for this drug
Dosing by Indication
| Indication | Dose | Route | Timing |
|---|---|---|---|
| CINV prevention (adults) | 8 mg | IV (single dose) | 30 min before chemo |
| PONV prevention (adults) | 4 mg | IV or IM | At end of surgery |
| Radiation-induced N&V | 8 mg | IV or oral | Before radiotherapy |
| Pediatric CINV (BSA 0.6-1.2 m²) | 5 mg/m² | IV | Before chemo |
Key Points
- Do NOT give rapid IV push - risk of QT prolongation and hypotension; minimum 30 seconds
- Ondansetron causes small but significant QT prolongation (especially first-generation 5-HT3 antagonists); avoid in patients with prolonged QTc or on other QT-prolonging drugs
- Compatible with dexamethasone via Y-site infusion (often co-administered for enhanced antiemetic effect)
- Dose reduction may be needed in hepatic insufficiency (extensive hepatic metabolism)
- No dose reduction needed in renal impairment or elderly patients
Sources: Katzung's Basic and Clinical Pharmacology, 16th Ed. (p. 1717); Pfizer Prescribing Information; StatPearls - Ondansetron
Adult dose
Finding Sources
Searching the Web
ondansetron adult dose injection IV IM complete dosing guidelines
Ondansetron Injection - Adult Doses
1. Chemotherapy-Induced Nausea & Vomiting (CINV)
| Regimen | Dose | Route | Timing |
|---|---|---|---|
| Standard (weight-based) | 0.15 mg/kg/dose x 3 doses (max 16 mg/dose) | IV infusion over 15 min | 1st dose 30 min before chemo; repeat at 4 hr and 8 hr |
| Fixed dose | 8 mg (slow IV or IM) | IV/IM | Immediately before chemo |
| Highly emetogenic chemo | Up to 32 mg/day total (in divided doses) | IV | Divided doses |
| Continuous infusion | 1 mg/hour | IV | Up to 24 hours |
Maximum single IV dose: 16 mg Maximum daily dose: 32 mg (0.45 mg/kg/day IV in 3 divided doses)
2. Post-Operative Nausea & Vomiting (PONV)
| Purpose | Dose | Route | Timing |
|---|---|---|---|
| Prevention | 4 mg | IV (over 30 sec - 2 min) or IM | At induction of anaesthesia |
| Treatment (established PONV) | 4 mg | IV or IM | Postoperatively |
- A second 4 mg dose does not provide additional benefit if the first prophylactic dose failed.
3. Radiation-Induced Nausea & Vomiting
| Situation | Dose | Route |
|---|---|---|
| Total body / abdominal irradiation | 8 mg | Slow IV or IM before each fraction |
4. Emergency Department / General Use
- Usual dose: 4-8 mg IV/PO as a single dose
- May go up to 16 mg as a single dose in non-elderly adults
- Elderly: initial dose should not exceed 8 mg, given as an infusion over 15 min
Dose Adjustments
| Condition | Adjustment |
|---|---|
| Severe hepatic impairment (Child-Pugh ≥ 10) | Max 8 mg/day (IV or oral) |
| Renal impairment | No dose adjustment needed |
| Elderly | Max 8 mg per dose; infuse over 15 min |
| Pregnancy (nausea/vomiting) | 8 mg IV over 15 min every 12 hr (third-line option) |
Summary in Brief
| Indication | Dose |
|---|---|
| CINV | 8 mg IV (or 0.15 mg/kg x 3) |
| PONV | 4 mg IV/IM |
| Max single IV dose | 16 mg |
| Max daily dose | 32 mg |
| Hepatic impairment | 8 mg/day max |
Sources: Goodman & Gilman's Pharmacological Basis of Therapeutics (adult dose table: 8-16 mg IV); Rosen's Emergency Medicine (4-8 mg IV, up to 16 mg); DailyMed FDA label; Fresenius Kabi PI
This is a shared conversation. Sign in to Orris to start your own chat.